Jayamas Medica Industri Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Jayamas Medica Industri Tbk. trades at Rp202 (market cap 5.47T, 9.71M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 11.2× Saraswanti Indoland Development Tbk.'s market cap, and Jayamas Medica Industri Tbk. is more actively traded (9.71M versus 1.51M). Which is the better fit depends on your goals.
| OMED | SWID | |
|---|---|---|
Market Cap | 5.47T | 490.04B |
Volume | 9.71M | 1.51M |
Lot | 97.09K | 15.14K |
Turnover | 1.94B | 137.63M |
Average Price | 200.06 | 90.94 |
Value | 1.94B | 137.63M |
Indicative Equilibrium Price | 202 | 92 |
Indicative Equilibrium Volume | 1.57K | 1.49K |
Trailing returns across standard periods
Latest headlines on both assets
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →